reports
ADMA Biologics Set to Join S&P SmallCap 600 Index
ADMA Biologics Set to Join S&P SmallCap 600 Index RAMSEY, N.J. and BOCA RATON, Fla., Sept. 17, 2024 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, today announced it will join the S&P SmallCap 600 index, effective prior to the open of trading on Monday, September 23, 2024. The S&P SmallCap 600 seeks to measure the small-cap segment of the U.S. equity market. "ADMA’s inclusion in the S&P SmallCap 600 index is a significant milestone for our com...
ADMA Biologics to Participate in the 2024 Cantor Global Healthcare Con...
ADMA Biologics to Participate in the 2024 Cantor Global Healthcare Conference RAMSEY, N.J. and BOCA RATON, Fla., Sept. 10, 2024 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, today announced Adam Grossman, President and Chief Executive Officer, will participate in a fireside chat at the 2024 Cantor Global Healthcare Conference in New York, NY on September 17, 2024, at 3:05 p.m. ET. A live audio webcast of the call will be availa...
- MarketLine Department
Glacier Bancorp, Inc. - Mergers & Acquisitions (M&A), Partnerships & A...
Summary Marketline's Glacier Bancorp, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Glacier Bancorp, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Inv...
ADMA Biologics Announces Partial Paydown of Revolving Credit Facility
ADMA Biologics Announces Partial Paydown of Revolving Credit Facility Cash on Hand Utilized to Repay $30 Million of Revolving Credit Facility to Ares Capital with No Prepayment Penalties Lowers ADMA’s Total Debt to $105 Million, a 22% Reduction Further Supports Earnings Growth Outlook RAMSEY, N.J. and BOCA RATON, Fla., Aug. 14, 2024 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, today announced it has repaid $30 million from it...
ADMA Biologics Announces Second Quarter 2024 Financial Results and Pro...
ADMA Biologics Announces Second Quarter 2024 Financial Results and Provides Business Update 2Q 2024 Total Revenue of $107.2 Million, a 78% Increase Y-o-Y 2Q 2024 GAAP Net Income of $32.1 Million, a $38.4 Million Increase Y-o-Y 2Q 2024 Adjusted EBITDA(1) of $44.5 Million, a Nearly 600% Increase Y-o-Y Commercial Scale Production of ADMA’s Innovative Biologics Manufacturing Process Supports a Potential Yield Enhancement of Approximately 20% from Same Starting Plasma FY 2024 and 2025 Total Revenue Guidance Increased to More Than $400 Million and $445 Million, Respectively FY 2024 GAAP...
First Interstate Bancsystem Inc: 1 director
A director at First Interstate Bancsystem Inc bought/sold/gave away 25,282 shares at 0.000USD and the significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors...
ADMA Biologics to Report Second Quarter 2024 Financial Results on Augu...
ADMA Biologics to Report Second Quarter 2024 Financial Results on August 8, 2024 Conference Call Scheduled for August 8, 2024, at 4:30 p.m. ET RAMSEY, N.J. and BOCA RATON, Fla., Aug. 01, 2024 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, today announced that it will report second quarter 2024 financial results on August 8, 2024, after the U.S. financial markets close. ADMA’s management team will host a live conference call and...
Altisource Announces Second Quarter 2024 Financial Results
Altisource Announces Second Quarter 2024 Financial Results LUXEMBOURG, July 25, 2024 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage industries, today reported financial results for the second quarter 2024. “We had a strong second quarter and believe we are on track to achieve our 2024 guidance of 13% to 32% service revenue growth over 2023 and Adjusted EBITDA(1) of between $17.5 million and $22.5 million in 2024, a $21 million improvement in Adjusted EBITDA(1) over...
Altisource Portfolio Solutions S.A. Schedules Second Quarter 2024 Conf...
Altisource Portfolio Solutions S.A. Schedules Second Quarter 2024 Conference Call LUXEMBOURG, July 23, 2024 (GLOBE NEWSWIRE) -- On Thursday, July 25, 2024, Altisource Portfolio Solutions S.A. (“Altisource”) (NASDAQ: ASPS) will report earnings for the second quarter 2024. A press release and presentation will be available on Altisource’s website in the Investor Relations section. Altisource will also host a conference call at 8:30 a.m. EDT on the same day to discuss its second quarter 2024 results. A link to the live audio webcast will be available on Altisource’s website in the Investor ...
- MarketLine Department
Glacier Bancorp Inc - Company Profile and SWOT Analysis
Summary Glacier Bancorp Inc - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Glacier Bancorp Inc (Glacier) is a multi-bank holding company that offers banking and other related financial solutions to individuals, corporates, communities, SMEs, and public entities, through it...
- MarketLine Department
Trustmark Corp - Company Profile and SWOT Analysis
Summary Trustmark Corp - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Trustmark Corp (Trustmark) is a bank holding company, which offers banking, insurance, and wealth management solutions through its subsidiaries. Its portfolio of offerings includes retail and corporate b...
Lenders One Launches L1 Insurance for Homeowners and Automobile Insura...
Lenders One Launches L1 Insurance for Homeowners and Automobile Insurance Lenders One Members can help their borrowers obtain quotes from multiple insurance providers to secure homeowners and automobile insurance coverage EL PASO, Texas, May 22, 2024 (GLOBE NEWSWIRE) -- Lenders One® Cooperative (“L1” or “Lenders One”), a national alliance of independent mortgage bankers, banks and credit unions, managed by a subsidiary of Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), today announces the availability of Lenders One Insurance (“L1 Insurance”), a homeo...
ADMA Biologics Announces First Quarter 2024 Financial Results and Prov...
ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update 1Q 2024 Total Revenue of $81.9 Million, a 44% Increase Y-o-Y 1Q 2024 GAAP Net Income of $17.8 Million, a $24.6 Million Increase Y-o-Y 1Q 2024 Adjusted EBITDA(1) of $26.4 Million, a 970% Increase Y-o-Y FY 2024 and 2025 Total Revenue Guidance Increased to More Than $355 Million and $410 Million, Respectively FY 2024 Net Income Guidance Increased to More Than $85 Million and Adjusted EBITDA Guidance Increased to More Than $110 Million FY 2025 Net Income Guidance Increased to More than $135 Milli...
ADMA Biologics to Report First Quarter 2024 Financial Results on May 9...
ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024 Conference Call Scheduled for May 9, 2024, at 4:30 p.m. ET RAMSEY, N.J. and BOCA RATON, Fla., May 02, 2024 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, today announced that it will report first quarter 2024 financial results on May 9, 2024, after the U.S. financial markets close. ADMA’s management team will host a live conference call and audio webca...
- MarketLine Department
Columbia Banking System Inc - Company Profile and SWOT Analysis
Summary Columbia Banking System Inc - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Columbia Banking System Inc (CBS) is a bank holding company that offers a range of banking services. CBS provides deposit accounts such as checking and savings, money market, individual reti...
Altisource Announces First Quarter 2024 Financial Results
Altisource Announces First Quarter 2024 Financial Results LUXEMBOURG, April 25, 2024 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage industries, today reported financial results for the first quarter 2024. “I am very pleased with our first quarter performance. We generated $4.6 million of Adjusted EBITDA(1), marking our best quarterly performance since the third quarter of 2020, on $36.9 million of service revenue. We are winning meaningful new business and ramping ...
Altisource Portfolio Solutions S.A. Schedules First Quarter 2024 Confe...
Altisource Portfolio Solutions S.A. Schedules First Quarter 2024 Conference Call LUXEMBOURG, April 18, 2024 (GLOBE NEWSWIRE) -- On Thursday, April 25, 2024, Altisource Portfolio Solutions S.A. (“Altisource”) (NASDAQ: ASPS) will report earnings for the first quarter 2024. A press release and presentation will be available on Altisource’s website in the Investor Relations section. Altisource will also host a conference call at 8:30 a.m. EDT on the same day to discuss its first quarter 2024 results. A link to the live audio webcast will be available on Altisource’s website in the Investor R...
ADMA Biologics Announces FDA Approvals of Extended Room Temperature St...
ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM® FDA Approval Provides for Room Temperature (25°C) Storage Conditions for up to 4 Weeks at Any Point During the 36-Month Approved Shelf Life Extends the Prior Room Temperature Storage Allowance for the Full 36-months for ASCENIV and BIVIGAM Provides for Improved Inventory Management and Ease of Product Administration to Patients Approval of Extended Ambient Storage Conditions for ASCENIV & BIVIGAM is Immediately Effective and Now Commercially Available to U.S. Healthcare Pr...
Altisource Announces Fourth Quarter and Full Year 2023 Financial Resul...
Altisource Announces Fourth Quarter and Full Year 2023 Financial Results LUXEMBOURG, March 07, 2024 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage industries, today reported financial results for the fourth quarter and full year 2023. “I am pleased with our performance in 2023 as we continue to strengthen our financial position and win new business which has not fully ramped. In the face of serious market headwinds for both Business Segments, Service revenue ...
ADMA Biologics to Participate in the Raymond James Institutional Inves...
ADMA Biologics to Participate in the Raymond James Institutional Investor Conference RAMSEY, N.J. and BOCA RATON, Fla., March 05, 2024 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, today announced Adam Grossman, President and Chief Executive Officer, will participate in a fireside chat at the Raymond James Institutional Investor Conference on March 6, 2024, at 11:35 a.m. ET. A live audio webcast of the call will be available ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.